03-05 12:19 1st Sub. (Buff) H.B. 500
Kirk A. Cullimore proposes the following substitute bill:
1
Controlled Substance Modifications
2025 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Jennifer Dailey-Provost
Senate Sponsor: Kirk A. Cullimore
2
3
LONG TITLE
4
General Description:
5
This bill amends provisions related to the Controlled Substances Act.
6
Highlighted Provisions:
7
This bill:
8
▸ classifies amanita muscaria as a controlled substance; and
9
▸ provides for the automatic rescheduling of a certain type of psilocybin if rescheduled by
10
the federal government.
11
Money Appropriated in this Bill:
12
None
13
Other Special Clauses:
14
None
15
Utah Code Sections Affected:
16
AMENDS:
17
58-37-4, as last amended by Laws of Utah 2024, Chapter 298
18
19
Be it enacted by the Legislature of the state of Utah:
20
Section 1. Section 58-37-4 is amended to read:
21
58-37-4 . Schedules of controlled substances -- Schedules I through V -- Findings
22
required -- Specific substances included in schedules.
23
(1) There are established five schedules of controlled substances known as Schedules I, II,
24
III, IV, and V which consist of substances listed in this section.
25
(2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by the
26
official name, common or usual name, chemical name, or brand name designated:
27
(a) Schedule I:
28
(i) Unless specifically excepted or unless listed in another schedule, any of the
29
following opiates, including their isomers, esters, ethers, salts, and salts of
1st Sub. H.B. 500 1st Sub. (Buff) H.B. 500 03-05 12:19
30
isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and
31
salts is possible within the specific chemical designation:
32
(A) Acetyl-alpha-methylfentanyl
33
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
34
(B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
35
(C) Acetylmethadol;
36
(D) Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);
37
(E) Allylprodine;
38
(F) Alphacetylmethadol, except levo-alphacetylmethadol also known as
39
levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
40
(G) Alphameprodine;
41
(H) Alphamethadol;
42
(I) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
43
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
44
(J) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
45
piperidinyl]-N-phenylpropanamide);
46
(K) Benzylpiperazine;
47
(L) Benzethidine;
48
(M) Betacetylmethadol;
49
(N) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
50
piperidinyl]-N-phenylpropanamide);
51
(O) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
52
phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
53
(P) Betameprodine;
54
(Q) Betamethadol;
55
(R) Betaprodine;
56
(S) Butyryl fentanyl (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);
57
(T) Clonitazene;
58
(U) Cyclopropyl fentanyl
59
(N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
60
(V) Dextromoramide;
61
(W) Diampromide;
62
(X) Diethylthiambutene;
63
(Y) Difenoxin;
- 2 - 03-05 12:19 1st Sub. (Buff) H.B. 500
64
(Z) Dimenoxadol;
65
(AA) Dimepheptanol;
66
(BB) Dimethylthiambutene;
67
(CC) Dioxaphetyl butyrate;
68
(DD) Dipipanone;
69
(EE) Ethylmethylthiambutene;
70
(FF) Etizolam
71
(1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);
72
(GG) Etonitazene;
73
(HH) Etoxeridine;
74
(II) Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
75
furan-2-carboxamide);
76
(JJ) Furethidine;
77
(KK) Hydroxypethidine;
78
(LL) Ketobemidone;
79
(MM) Levomoramide;
80
(NN) Levophenacylmorphan;
81
(OO) Methoxyacetyl fentanyl
82
(2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);
83
(PP) Morpheridine;
84
(QQ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
85
(RR) Noracymethadol;
86
(SS) Norlevorphanol;
87
(TT) Normethadone;
88
(UU) Norpipanone;
89
(VV) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
90
propanamide);
91
(WW) Para-fluoroisobutyryl fentanyl
92
(N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
93
(XX) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
94
(YY) Phenadoxone;
95
(ZZ) Phenampromide;
96
(AAA) Phenomorphan;
97
(BBB) Phenoperidine;
- 3 - 1st Sub. (Buff) H.B. 500 03-05 12:19
98
(CCC) Piritramide;
99
(DDD) Proheptazine;
100
(EEE) Properidine;
101
(FFF) Propiram;
102
(GGG) Racemoramide;
103
(HHH) Tetrahydrofuran fentanyl
104
(N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
105
(III) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
106
(JJJ) Tilidine;
107
(KKK) Trimeperidine;
108
(LLL) 3-methylfentanyl, including the optical and geometric isomers
109
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);
110
(MMM) 3-methylthiofentanyl
111
(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
112
(NNN) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide also
113
known as U-47700; and
114
(OOO) 4-cyano CUMYL-BUTINACA.
115
(ii) Unless specifically excepted or unless listed in another schedule, any of the
116
following opium derivatives, their salts, isomers, and salts of isomers when the
117
existence of the salts, isomers, and salts of isomers is possible within the specific
118
chemical designation:
119
(A) Acetorphine;
120
(B) Acetyldihydrocodeine;
121
(C) Benzylmorphine;
122
(D) Codeine methylbromide;
123
(E) Codeine-N-Oxide;
124
(F) Cyprenorphine;
125
(G) Desomorphine;
126
(H) Dihydromorphine;
127
(I) Drotebanol;
128
(J) Etorphine (except hydrochloride salt);
129
(K) Heroin;
130
(L) Hydromorphinol;
131
(M) Methyldesorphine;
- 4 - 03-05 12:19 1st Sub. (Buff) H.B. 500
132
(N) Methylhydromorphine;
133
(O) Morphine methylbromide;
134
(P) Morphine methylsulfonate;
135
(Q) Morphine-N-Oxide;
136
(R) Myrophine;
137
(S) Nicocodeine;
138
(T) Nicomorphine;
139
(U) Normorphine;
140
(V) Pholcodine; and
141
(W) Thebacon.
142
(iii) Unless specifically excepted or unless listed in another schedule, any material,
143
compound, mixture, or preparation which contains any quantity of the following
144
hallucinogenic substances, or which contains any of their salts, isomers, and salts
145
of isomers when the existence of the salts, isomers, and salts of isomers is possible
146
within the specific chemical designation; as used in this Subsection (2)(a)(iii)
147
only, "isomer" includes the optical, position, and geometric isomers:
148
(A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase; α
149
-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;
150
(B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
151
4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
152
(C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
153
2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB;
154
2C-B, Nexus;
155
(D) 2,5-dimethoxyamphetamine, some trade or other names: 2,5-dimethoxy-α
156
-methylphenethylamine; 2,5-DMA;
157
(E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
158
(F) 4-methoxyamphetamine, some trade or other names: 4-methoxy-α
159
-methylphenethylamine; paramethoxyamphetamine, PMA;
160
(G) 5-methoxy-3,4-methylenedioxyamphetamine;
161
(H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
162
4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
163
(I) 3,4-methylenedioxy amphetamine;
164
(J) 3,4-methylenedioxymethamphetamine (MDMA);
165
(K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
- 5 - 1st Sub. (Buff) H.B. 500 03-05 12:19
166
alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE,
167
MDEA;
168
(L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
169
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy
170
MDA;
171
(M) 3,4,5-trimethoxy amphetamine;
172
(N) Bufotenine, some trade and other names: 3-(β
173
-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol;
174
N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
175
(O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
176
(P) Dimethyltryptamine, some trade or other names: DMT;
177
(Q) Ibogaine, some trade and other names: 7-Ethyl-6,6β
178
,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2]
179
azepino [5,4-b] indole; Tabernanthe iboga;
180
(R) Lysergic acid diethylamide;
181
(S) Marijuana;
182
(T) Mescaline;
183
(U) Parahexyl, some trade or other names:
184
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran;
185
Synhexyl;
186
(V) Peyote, meaning all parts of the plant presently classified botanically as
187
Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any
188
extract from any part of such plant, and every compound, manufacture, salts,
189
derivative, mixture, or preparation of such plant, its seeds or extracts
190
(Interprets 21 USC 812(c), Schedule I(c) (12));
191
(W) N-ethyl-3-piperidyl benzilate;
192
(X) N-methyl-3-piperidyl benzilate;
193
(Y) Psilocybin, except as provided in Subsection (3);
194
(Z) Psilocyn;
195
(AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
196
(cannabis plant), except for marijuana as defined in Subsection 58-37-2
197
(1)(aa)(i)(E), as well as synthetic equivalents of the substances contained in the
198
cannabis plant, or in the resinous extractives of Cannabis, sp. and/or synthetic
199
substances, derivatives, and their isomers with similar chemical structure and
- 6 - 03-05 12:19 1st Sub. (Buff) H.B. 500
200
pharmacological activity to those substances contained in the plant, such as the
201
following: Δ1 cis or trans tetrahydrocannabinol, and their optical isomers Δ6 cis or
202
trans tetrahydrocannabinol, and their optical isomers Δ3,4 cis or trans
203
tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
204
substances is not internationally standardized, compounds of these structures,
205
regardless of numerical designation of atomic positions covered;
206
(BB) Ethylamine analog of phencyclidine, some trade or other names:
207
N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
208
N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
209
(CC) Pyrrolidine analog of phencyclidine, some trade or other names:
210
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
211
(DD) Thiophene analog of phencyclidine, some trade or other names:
212
1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine,
213
TPCP, TCP; and
214
(EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
215
(iv) Unless specifically excepted or unless listed in another schedule, any material
216
compound, mixture, or preparation which contains any quantity of the following
217
substances having a depressant effect on the central nervous system, including its
218
salts, isomers, and salts of isomers when the existence of the salts, isomers, and
219
salts of isomers is possible within the specific chemical designation:
220
(A) Mecloqualone; and
221
(B) Methaqualone.
222
(v) Any material, compound, mixture, or preparation containing any quantity of the
223
following substances having a stimulant effect on the central nervous system,
224
including their salts, isomers, and salts of isomers:
225
(A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline;
226
or 4,5-dihydro-5-phenyl-2-oxazolamine;
227
(B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
228
alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
229
(C) Fenethylline;
230
(D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
231
alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
232
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;
233
N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432,
- 7 - 1st Sub. (Buff) H.B. 500 03-05 12:19
234
its salts, optical isomers, and salts of optical isomers;
235
(E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
236
(F) N-ethylamphetamine; and
237
(G) N,N-dimethylamphetamine, also known as
238
N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
239
(vi) Any material, compound, mixture, or preparation which contains any quantity of
240
the following substances, including their optical isomers, salts, and salts of
241
isomers, subject to temporary emergency scheduling:
242
(A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
243
(B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
244
(vii) Unless specifically excepted or unless listed in another schedule, any material,
245
compound, mixture, or preparation which contains any quantity of gamma
246
hydroxy butyrate (gamma hydrobutyric acid), including its salts, isomers, and
247
salts of isomers.
248
(b) Schedule II:
249
(i) Unless specifically excepted or unless listed in another schedule, any of the
250
following substances whether produced directly or indirectly by extraction from
251
substances of vegetable origin, or independently by means of chemical synthesis,
252
or by a combination of extraction and chemical synthesis:
253
(A) Opium and opiate, and any salt, compound, derivative, or preparation of
254
opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene,
255
naloxone, and naltrexone, and their respective salts, but including:
256
(I) Raw opium;
257
(II) Opium extracts;
258
(III) Opium fluid;
259
(IV) Powdered opium;
260
(V) Granulated opium;
261
(VI) Tincture of opium;
262
(VII) Codeine;
263
(VIII) Ethylmorphine;
264
(IX) Etorphine hydrochloride;
265
(X) Hydrocodone;
266
(XI) Hydromorphone;
267
(XII) Metopon;
- 8 - 03-05 12:19 1st Sub. (Buff) H.B. 500
268
(XIII) Morphine;
269
(XIV) Oxycodone;
270
(XV) Oxymorphone; and
271
(XVI) Thebaine;
272
(B) Any salt, compound, derivative, or preparation which is chemically equivalent
273
or identical with any of the substances referred to in Subsection (2)(b)(i)(A),
274
except that these substances may not include the isoquinoline alkaloids of
275
opium;
276
(C) Opium poppy and poppy straw;
277
(D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves,
278
and any salt, compound, derivative, or preparation which is chemically
279
equivalent or identical with any of these substances, and includes cocaine and
280
ecgonine, their salts, isomers, derivatives, and salts of isomers and derivatives,
281
whether derived from the coca plant or synthetically produced, except the
282
substances may not include decocainized coca leaves or extraction of coca
283
leaves, which extractions do not contain cocaine or ecgonine; and
284
(E) Concentrate of poppy straw, which means the crude extract of poppy straw in
285
either liquid, solid, or powder form which contains the phenanthrene alkaloids
286
of the opium poppy.
287
(ii) Unless specifically excepted or unless listed in another schedule, any of the
288
following opiates, including their isomers, esters, ethers, salts, and salts of
289
isomers, esters, and ethers, when the existence of the isomers, esters, ethers, and
290
salts is possible within the specific chemical designation, except dextrorphan and
291
levopropoxyphene:
292
(A) Alfentanil;
293
(B) Alphaprodine;
294
(C) Anileridine;
295
(D) Bezitramide;
296
(E) Bulk dextropropoxyphene (nondosage forms);
297
(F) Carfentanil;
298
(G) Dihydrocodeine;
299
(H) Diphenoxylate;
300
(I) Fentanyl;
301
(J) Isomethadone;
- 9 - 1st Sub. (Buff) H.B. 500 03-05 12:19
302
(K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
303
levomethadyl acetate, or LAAM;
304
(L) Levomethorphan;
305
(M) Levorphanol;
306
(N) Metazocine;
307
(O) Methadone;
308
(P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
309
(Q) Moramide-Intermediate, 2-methyl-3-morpholino-1,
310
1-diphenylpropane-carboxylic acid;
311
(R) Pethidine (meperidine);
312
(S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
313
(T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
314
(U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
315
(V) Phenazocine;
316
(W) Piminodine;
317
(X) Racemethorphan;
318
(Y) Racemorphan;
319
(Z) Remifentanil; and
320
(AA) Sufentanil.
321
(iii) Unless specifically excepted or unless listed in another schedule, any material,
322
compound, mixture, or preparation which contains any quantity of the following
323
substances having a stimulant effect on the central nervous system:
324
(A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
325
(B) Methamphetamine, its salts, isomers, and salts of its isomers;
326
(C) Phenmetrazine and its salts; and
327
(D) Methylphenidate.
328
(iv) Unless specifically excepted or unless listed in another schedule, any material,
329
compound, mixture, or preparation which contains any quantity of the following
330
substances having a depressant effect on the central nervous system, including its
331
salts, isomers, and salts of isomers when the existence of the salts, isomers, and
332
salts of isomers is possible within the specific chemical designation:
333
(A) Amobarbital;
334
(B) Glutethimide;
335
(C) Pentobarbital;
- 10 - 03-05 12:19 1st Sub. (Buff) H.B. 500
336
(D) Phencyclidine;
337
(E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
338
1-piperidinocyclohexanecarbonitrile (PCC); and
339
(F) Secobarbital.
340
(v)(A) Unless specifically excepted or unless listed in another schedule, any
341
material, compound, mixture, or preparation which contains any quantity of
342
Phenylacetone.
343
(B) Some of these substances may be known by trade or other names:
344
phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
345
(vi) Nabilone, another name for nabilone: (±
346
)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
347
6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
348
(vii) A drug product or preparation that contains any component of marijuana,
349
including tetrahydrocannabinol, and is approved by the United States Food and
350
Drug Administration and scheduled by the Drug Enforcement Administration in
351
Schedule II of the federal Controlled Substances Act, Title II, P.L. 91-513.
352
(c) Schedule III:
353
(i) Unless specifically excepted or unless listed in another schedule, any material,
354
compound, mixture, or preparation which contains any quantity of the following
355
substances having a stimulant effect on the central nervous system, including its
356
salts, isomers whether optical, position, or geometric, and salts of the isomers
357
when the existence of the salts, isomers, and salts of isomers is possible within the
358
specific chemical designation:
359
(A) Those compounds, mixtures, or preparations in dosage unit form containing
360
any stimulant substances listed in Schedule II, which compounds, mixtures, or
361
preparations were listed on August 25, 1971, as excepted compounds under
362
Section 1308.32 of Title 21 of the Code of Federal Regulations, and any other
363
drug of the quantitive composition shown in that list for those drugs or which
364
is the same except that it contains a lesser quantity of controlled substances;
365
(B) Benzphetamine;
366
(C) Chlorphentermine;
367
(D) Clortermine; and
368
(E) Phendimetrazine.
369
(ii) Unless specifically excepted or unless listed in another schedule, any material,
- 11 - 1st Sub. (Buff) H.B. 500 03-05 12:19
370
compound, mixture, or preparation which contains any quantity of the following
371
substances having a depressant effect on the central nervous system:
372
(A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
373
pentobarbital, or any salt of any of them, and one or more other active
374
medicinal ingredients which are not listed in any schedule;
375
(B) Any suppository dosage form containing amobarbital, secobarbital, or
376
pentobarbital, or any salt of any of these drugs which is approved by the United
377
States Food and Drug Administration for marketing only as a suppository;
378
(C) Any substance which contains any quantity of a derivative of barbituric acid
379
or any salt of any of them;
380
(D) Chlorhexadol;
381
(E) Buprenorphine;
382
(F) Any drug product containing gamma hydroxybutyric acid, including its salts,
383
isomers, and salts of isomers, for which an application is approved under the
384
federal Food, Drug, and Cosmetic Act, Section 505;
385
(G) Ketamine, its salts, isomers, and salts of isomers, some other names for
386
ketamine: ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
387
(H) Lysergic acid;
388
(I) Lysergic acid amide;
389
(J) Methyprylon;
390
(K) Sulfondiethylmethane;
391
(L) Sulfonethylmethane;
392
(M) Sulfonmethane; and
393
(N) Tiletamine and zolazepam or any of their salts, some trade or other names for
394
a tiletamine-zolazepam combination product: Telazol, some trade or other
395
names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade
396
or other names for zolazepam:
397
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e]
398
[1,4]-diazepin-7(1H)-one, flupyrazapon.
399
(iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in
400
a U.S. Food and Drug Administration approved drug product, some other names
401
for dronabinol:
402
(6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,
403
or (-)-delta-9-(trans)-tetrahydrocannabinol.
- 12 - 03-05 12:19 1st Sub. (Buff) H.B. 500
404
(iv) Nalorphine.
405
(v) Unless specifically excepted or unless listed in another schedule, any material,
406
compound, mixture, or preparation containing limited quantities of any of the
407
following narcotic drugs, or their salts calculated as the free anhydrous base or
408
alkaloid:
409
(A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
410
milligrams per dosage unit, with an equal or greater quantity of an isoquinoline
411
alkaloid of opium;
412
(B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
413
milligrams per dosage unit, with one or more active non-narcotic ingredients in
414
recognized therapeutic amounts;
415
(C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
416
more than 15 milligrams per dosage unit, with a fourfold or greater quantity of
417
an isoquinoline alkaloid of opium;
418
(D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not
419
more than 15 milligrams per dosage unit, with one or more active, non-narcotic
420
ingredients in recognized therapeutic amounts;
421
(E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more
422
than 90 milligrams per dosage unit, with one or more active non-narcotic
423
ingredients in recognized therapeutic amounts;
424
(F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
425
than 15 milligrams per dosage unit, with one or more active, non-narcotic
426
ingredients in recognized therapeutic amounts;
427
(G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams,
428
or not more than 25 milligrams per dosage unit, with one or more active,
429
non-narcotic ingredients in recognized therapeutic amounts; and
430
(H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams
431
with one or more active, non-narcotic ingredients in recognized therapeutic
432
amounts.
433
(vi) Unless specifically excepted or unless listed in another schedule, anabolic
434
steroids including any of the following or any isomer, ester, salt, or derivative of
435
the following that promotes muscle growth:
436
(A) Boldenone;
437
(B) Chlorotestosterone (4-chlortestosterone);
- 13 - 1st Sub. (Buff) H.B. 500 03-05 12:19
438
(C) Clostebol;
439
(D) Dehydrochlormethyltestosterone;
440
(E) Dihydrotestosterone (4-dihydrotestosterone);
441
(F) Drostanolone;
442
(G) Ethylestrenol;
443
(H) Fluoxymesterone;
444
(I) Formebulone (formebolone);
445
(J) Mesterolone;
446
(K) Methandienone;
447
(L) Methandranone;
448
(M) Methandriol;
449
(N) Methandrostenolone;
450
(O) Methenolone;
451
(P) Methyltestosterone;
452
(Q) Mibolerone;
453
(R) Nandrolone;
454
(S) Norethandrolone;
455
(T) Oxandrolone;
456
(U) Oxymesterone;
457
(V) Oxymetholone;
458
(W) Stanolone;
459
(X) Stanozolol;
460
(Y) Testolactone;
461
(Z) Testosterone; and
462
(AA) Trenbolone.
463
(vii) Anabolic steroids expressly intended for administration through implants to
464
cattle or other nonhuman species, and approved by the Secretary of Health and
465
Human Services for use, may not be classified as a controlled substance.
466
(viii) A drug product or preparation that contains any component of marijuana,
467
including tetrahydrocannabinol, and is approved by the United States Food and
468
Drug Administration and scheduled by the Drug Enforcement Administration in
469
Schedule III of the federal Controlled Substances Act, Title II, P.L. 91-513.
470
(ix) Nabiximols.
471
(x) Amanita Muscaria.
- 14 - 03-05 12:19 1st Sub. (Buff) H.B. 500
472
(d) Schedule IV:
473
(i) Unless specifically excepted or unless listed in another schedule, any material,
474
compound, mixture, or preparation containing not more than 1 milligram of
475
difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit, or
476
any salts of any of them.
477
(ii) Unless specifically excepted or unless listed in another schedule, any material,
478
compound, mixture, or preparation which contains any quantity of the following
479
substances, including its salts, isomers, and salts of isomers when the existence of
480
the salts, isomers, and salts of isomers is possible within the specific chemical
481
designation:
482
(A) Alprazolam;
483
(B) Barbital;
484
(C) Bromazepam;
485
(D) Butorphanol;
486
(E) Camazepam;
487
(F) Carisoprodol;
488
(G) Chloral betaine;
489
(H) Chloral hydrate;
490
(I) Chlordiazepoxide;
491
(J) Clobazam;
492
(K) Clonazepam;
493
(L) Clorazepate;
494
(M) Clotiazepam;
495
(N) Cloxazolam;
496
(O) Delorazepam;
497
(P) Diazepam;
498
(Q) Dichloralphenazone;
499
(R) Estazolam;
500
(S) Ethchlorvynol;
501
(T) Ethinamate;
502
(U) Ethyl loflazepate;
503
(V) Fludiazepam;
504
(W) Flunitrazepam;
505
(X) Flurazepam;
- 15 - 1st Sub. (Buff) H.B. 500 03-05 12:19
506
(Y) Halazepam;
507
(Z) Haloxazolam;
508
(AA) Ketazolam;
509
(BB) Loprazolam;
510
(CC) Lorazepam;
511
(DD) Lormetazepam;
512
(EE) Mebutamate;
513
(FF) Medazepam;
514
(GG) Meprobamate;
515
(HH) Methohexital;
516
(II) Methylphenobarbital (mephobarbital);
517
(JJ) Midazolam;
518
(KK) Nimetazepam;
519
(LL) Nitrazepam;
520
(MM) Nordiazepam;
521
(NN) Oxazepam;
522
(OO) Oxazolam;
523
(PP) Paraldehyde;
524
(QQ) Pentazocine;
525
(RR) Petrichloral;
526
(SS) Phenobarbital;
527
(TT) Pinazepam;
528
(UU) Prazepam;
529
(VV) Quazepam;
530
(WW) Temazepam;
531
(XX) Tetrazepam;
532
(YY) Tramadol;
533
(ZZ) Triazolam;
534
(AAA) Zaleplon; and
535
(BBB) Zolpidem.
536
(iii) Any material, compound, mixture, or preparation of fenfluramine which contains
537
any quantity of the following substances, including its salts, isomers whether
538
optical, position, or geometric, and salts of the isomers when the existence of the
539
salts, isomers, and salts of isomers is possible.
- 16 - 03-05 12:19 1st Sub. (Buff) H.B. 500
540
(iv) Unless specifically excepted or unless listed in another schedule, any material,
541
compound, mixture, or preparation which contains any quantity of the following
542
substances having a stimulant effect on the central nervous system, including its
543
salts, isomers whether optical, position, or geometric isomers, and salts of the
544
isomers when the existence of the salts, isomers, and salts of isomers is possible
545
within the specific chemical designation:
546
(A) Cathine ((+)-norpseudoephedrine);
547
(B) Diethylpropion;
548
(C) Fencamfamine;
549
(D) Fenproprex;
550
(E) Mazindol;
551
(F) Mefenorex;
552
(G) Modafinil;
553
(H) Pemoline, including organometallic complexes and chelates thereof;
554
(I) Phentermine;
555
(J) Pipradrol;
556
(K) Sibutramine; and
557
(L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
558
(v) Unless specifically excepted or unless listed in another schedule, any material,
559
compound, mixture, or preparation which contains any quantity of
560
dextropropoxyphene (alpha-(+)-4-dimethylamino-1,
561
2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
562
(vi) A drug product or preparation that contains any component of marijuana and is
563
approved by the United States Food and Drug Administration and scheduled by
564
the Drug Enforcement Administration in Schedule IV of the federal Controlled
565
Substances Act, Title II, P.L. 91-513.
566
(e) Schedule V:
567
(i) Any compound, mixture, or preparation containing any of the following limited
568
quantities of narcotic drugs, or their salts calculated as the free anhydrous base or
569
alkaloid, which includes one or more non-narcotic active medicinal ingredients in
570
sufficient proportion to confer upon the compound, mixture, or preparation
571
valuable medicinal qualities other than those possessed by the narcotic drug alone:
572
(A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
573
(B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
- 17 - 1st Sub. (Buff) H.B. 500 03-05 12:19
574
grams;
575
(C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
576
grams;
577
(D) not more than 2.5 milligrams of diphenoxylate and not less than 25
578
micrograms of atropine sulfate per dosage unit;
579
(E) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
580
(F) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
581
atropine sulfate per dosage unit; and
582
(G) unless specifically exempted or excluded or unless listed in another schedule,
583
any material, compound, mixture, or preparation which contains Pyrovalerone
584
having a stimulant effect on the central nervous system, including its salts,
585
isomers, and salts of isomers.
586
(ii) A drug product or preparation that contains any component of marijuana,
587
including cannabidiol, and is approved by the United States Food and Drug
588
Administration and scheduled by the Drug Enforcement Administration in
589
Schedule V of the federal Controlled Substances Act, Title II, P.L. 91-513.
590
(iii) Gabapentin.
591
(3) If the federal government schedules the pharmaceutical composition of
592
crystallinepolymorph psilocybin in a schedule that is not schedule I, that composition is
593
deemed scheduled under this section in the same schedule that the composition is
594
scheduled under 21 U.S.C. Sec. 812 and 21 C.F.R. Sec. 1308.14.
595
Section 2. Effective Date.
596
This bill takes effect on May 7, 2025.
- 18 -